Schedule 13D Filing for Neuronetics, Inc. by Jorey Chernett

Jorey Chernett, a US citizen and private investor, has filed a Schedule 13D detailing his beneficial ownership of Neuronetics, Inc. common stock. He previously reported ownership on a Schedule 13G and this filing supersedes that. Chernett acquired 9,778,718 shares for $19,557,436 in private transactions using personal funds. His current beneficial ownership is 14.12% of the outstanding shares, an increase from 10.85%. He believes the stock was undervalued and may increase or decrease his position based on market conditions and investment opportunities. Chernett has not been convicted in criminal proceedings in the last five years and was not a party to any civil proceedings that would subject him to judgments under federal or state securities laws. He has no current plans or proposals that would lead to a change in control or other significant corporate actions, but reserves the right to take various actions regarding his investment in the future, including engaging with the company's management and board, or selling shares.